Brent Nicklas founded Lexington Partners in 1994 and currently serves as managing partner, overseeing private equity secondary and co-investment funds. He discusses global opportunities for secondary investors
Q: At $7 billion, Lexington Capital Partners VII is 80% larger than its predecessor. What does this say about the secondary investment market? A: When we started in this business in the early 1990s the...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.